insights_auto
Why is ARGX up 2.89%?
Dive Deeperchevron_right
ARGX:NASDAQ
argenx SE - ADR
$920.66
arrow_upward
+2.89%(+25.89) 1D
Nov 6, 12:08:19 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$894.78
High
$921.15
Low
$892.36
Mkt. cap
59.25B
Avg. vol.
454.74K
Volume
173.20K
P/E ratio
31.81
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$28.94
Beta
0.48
Shares outstanding
62.89M
No. of employees
2K
Open
$894.78
High
$921.15
Low
$892.36
Mkt. cap
59.25B
Avg. vol.
454.74K
Volume
173.20K
P/E ratio
31.81
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$28.94
Beta
0.48
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
Zacks
·
1 day ago
Best Biotech Stocks to Buy Now as AI Stocks Tank: ARGX
Yahoo Finance
·
1 day ago
Best Biotech Stocks to Buy Now as AI Stocks Tank: ARGX
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR
CEO-
Employees1.86K
FoundedApr 25, 2008
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteargenx.com